Home Featured Page 151

Featured

Latest

Q3’25 Psychedelic Lobbying Update

Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher

The Psychedelic News Feed: October 20 – 26, 2025

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

Q3’25 Investor Survey: What are Investors Most Concerned About?

Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction...

atai Life Sciences Secures Term Loan Facility for up to $175...

Field Trip Announces Closing of Plan of Arrangement and $19.9 Million...

PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support...

Psychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed...

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved...

MindMed Strengthens Board with Appointment of Two New Independent Directors

Opinions | Hallucinations of Meaning: If you can lie, so can...

PT346 – Kevin Balktick – Horizons Northwest, The Psilocybin Services Act,...

MindMed Reports Second Quarter 2022 Financial Results and Business Highlights

1...150151152...300 Page 151 of 300

Q3’25 Psychedelic Lobbying Update

Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher

The Psychedelic News Feed: October 20 – 26, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Q3’25 Psychedelic Lobbying Update

Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher

The Psychedelic News Feed: October 20 – 26, 2025

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

Q3’25 Investor Survey: What are Investors Most Concerned About?

Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction...

atai Life Sciences Secures Term Loan Facility for up to $175...

Field Trip Announces Closing of Plan of Arrangement and $19.9 Million...

PsyBio Therapeutics Strengthens IP Portfolio through Filing of Data to Support...

Psychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed...

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved...

MindMed Strengthens Board with Appointment of Two New Independent Directors

Opinions | Hallucinations of Meaning: If you can lie, so can...

PT346 – Kevin Balktick – Horizons Northwest, The Psilocybin Services Act,...

MindMed Reports Second Quarter 2022 Financial Results and Business Highlights

EDITOR PICKS

Q3’25 Psychedelic Lobbying Update

Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher

The Psychedelic News Feed: October 20 – 26, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY